Fibrinogen albumin ratio as a predictor marker of disease activity in ankylosing spondylitis

Abstract Background Fibrinogen albumin ratio (FAR) is recently considered as a new marker for inflammation. This study aimed to evaluate the value of FAR as a predictor biomarker of ankylosing spondylitis (AS) disease activity as well as its correlation with the spondyloarthritis research consortium...

Full description

Saved in:
Bibliographic Details
Main Authors: Mennatallah Mohammed Mohammed Mustafa, Hala Abdulhady‎ Saleh, ‎Mahmoud Mohamed ‎ Fathallah, ‎Osama Hassan ‎ Bakheet, Mohamed Abobakr El Seddik, ‎Mona Mohamed ‎ El Bably‎
Format: Article
Language:English
Published: SpringerOpen 2025-07-01
Series:The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:
Online Access:https://doi.org/10.1186/s43055-025-01518-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849237673848340480
author Mennatallah Mohammed Mohammed Mustafa
Hala Abdulhady‎ Saleh
‎Mahmoud Mohamed ‎ Fathallah
‎Osama Hassan ‎ Bakheet
Mohamed Abobakr El Seddik
‎Mona Mohamed ‎ El Bably‎
author_facet Mennatallah Mohammed Mohammed Mustafa
Hala Abdulhady‎ Saleh
‎Mahmoud Mohamed ‎ Fathallah
‎Osama Hassan ‎ Bakheet
Mohamed Abobakr El Seddik
‎Mona Mohamed ‎ El Bably‎
author_sort Mennatallah Mohammed Mohammed Mustafa
collection DOAJ
description Abstract Background Fibrinogen albumin ratio (FAR) is recently considered as a new marker for inflammation. This study aimed to evaluate the value of FAR as a predictor biomarker of ankylosing spondylitis (AS) disease activity as well as its correlation with the spondyloarthritis research consortium of Canada MRI index (SPARCC) of sacroiliac joints (SIJs) in detection of disease activity in AS. The study included 25 adult AS patients and 10 healthy controls who were matched for age and sex. Based on disease activity, patients were divided into two groups: Group (I) consisted of 15 patients with active disease with a BASDAI ≥ 4, and group (II) consisted of 10 patients with inactive disease with a BASDAI < 4. Results The mean of patients age was (35.2 years); patient’s disease duration range (1.5–18 years). AS patients with disease activity had a higher FAR and SPARCC MRI index in comparison with the remission and control groups (P < 0.01). FAR and the SPARCC MRI index were found to be positively correlated in patients with active illness (P < 0.01). Cut-off value of FAR > 0.086, SPARCC index > 4. FAR and SPARCC MRI index can significantly differentiate between active and inactive group (P < 0.001) with 100% sensitivity and specificity. FAR can significantly differentiate between AS patients and health controls (P < 0.001), with 80% sensitivity and 100% specificity. SPARCC index also can significantly differentiate between AS patients and health controls (P < 0.001) but with 88% sensitivity and 100% specificity. Conclusions The study concluded that FAR and SPARCC MRI index were elevated in patients with active AS disease. FAR and SPARCC MRI index can serve as a new parameter in monitoring activity in ankylosing spondylitis disease.
format Article
id doaj-art-28e9d1f86a5e4d908eb5e43f397d43ac
institution Kabale University
issn 2090-4762
language English
publishDate 2025-07-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Radiology and Nuclear Medicine
spelling doaj-art-28e9d1f86a5e4d908eb5e43f397d43ac2025-08-20T04:01:53ZengSpringerOpenThe Egyptian Journal of Radiology and Nuclear Medicine2090-47622025-07-0156111910.1186/s43055-025-01518-wFibrinogen albumin ratio as a predictor marker of disease activity in ankylosing spondylitisMennatallah Mohammed Mohammed Mustafa0Hala Abdulhady‎ Saleh1‎Mahmoud Mohamed ‎ Fathallah2‎Osama Hassan ‎ Bakheet3Mohamed Abobakr El Seddik4‎Mona Mohamed ‎ El Bably‎5Ministry of Public HealthAin Shams UniversityAin Shams UniversityArmed Forces College of MedicineArmed Forces College of MedicineAin Shams UniversityAbstract Background Fibrinogen albumin ratio (FAR) is recently considered as a new marker for inflammation. This study aimed to evaluate the value of FAR as a predictor biomarker of ankylosing spondylitis (AS) disease activity as well as its correlation with the spondyloarthritis research consortium of Canada MRI index (SPARCC) of sacroiliac joints (SIJs) in detection of disease activity in AS. The study included 25 adult AS patients and 10 healthy controls who were matched for age and sex. Based on disease activity, patients were divided into two groups: Group (I) consisted of 15 patients with active disease with a BASDAI ≥ 4, and group (II) consisted of 10 patients with inactive disease with a BASDAI < 4. Results The mean of patients age was (35.2 years); patient’s disease duration range (1.5–18 years). AS patients with disease activity had a higher FAR and SPARCC MRI index in comparison with the remission and control groups (P < 0.01). FAR and the SPARCC MRI index were found to be positively correlated in patients with active illness (P < 0.01). Cut-off value of FAR > 0.086, SPARCC index > 4. FAR and SPARCC MRI index can significantly differentiate between active and inactive group (P < 0.001) with 100% sensitivity and specificity. FAR can significantly differentiate between AS patients and health controls (P < 0.001), with 80% sensitivity and 100% specificity. SPARCC index also can significantly differentiate between AS patients and health controls (P < 0.001) but with 88% sensitivity and 100% specificity. Conclusions The study concluded that FAR and SPARCC MRI index were elevated in patients with active AS disease. FAR and SPARCC MRI index can serve as a new parameter in monitoring activity in ankylosing spondylitis disease.https://doi.org/10.1186/s43055-025-01518-wSpondylitisAnkylosingSacroiliac jointFibrinogenMagnetic resonance imagingAlbumins
spellingShingle Mennatallah Mohammed Mohammed Mustafa
Hala Abdulhady‎ Saleh
‎Mahmoud Mohamed ‎ Fathallah
‎Osama Hassan ‎ Bakheet
Mohamed Abobakr El Seddik
‎Mona Mohamed ‎ El Bably‎
Fibrinogen albumin ratio as a predictor marker of disease activity in ankylosing spondylitis
The Egyptian Journal of Radiology and Nuclear Medicine
Spondylitis
Ankylosing
Sacroiliac joint
Fibrinogen
Magnetic resonance imaging
Albumins
title Fibrinogen albumin ratio as a predictor marker of disease activity in ankylosing spondylitis
title_full Fibrinogen albumin ratio as a predictor marker of disease activity in ankylosing spondylitis
title_fullStr Fibrinogen albumin ratio as a predictor marker of disease activity in ankylosing spondylitis
title_full_unstemmed Fibrinogen albumin ratio as a predictor marker of disease activity in ankylosing spondylitis
title_short Fibrinogen albumin ratio as a predictor marker of disease activity in ankylosing spondylitis
title_sort fibrinogen albumin ratio as a predictor marker of disease activity in ankylosing spondylitis
topic Spondylitis
Ankylosing
Sacroiliac joint
Fibrinogen
Magnetic resonance imaging
Albumins
url https://doi.org/10.1186/s43055-025-01518-w
work_keys_str_mv AT mennatallahmohammedmohammedmustafa fibrinogenalbuminratioasapredictormarkerofdiseaseactivityinankylosingspondylitis
AT halaabdulhadysaleh fibrinogenalbuminratioasapredictormarkerofdiseaseactivityinankylosingspondylitis
AT mahmoudmohamedfathallah fibrinogenalbuminratioasapredictormarkerofdiseaseactivityinankylosingspondylitis
AT osamahassanbakheet fibrinogenalbuminratioasapredictormarkerofdiseaseactivityinankylosingspondylitis
AT mohamedabobakrelseddik fibrinogenalbuminratioasapredictormarkerofdiseaseactivityinankylosingspondylitis
AT monamohamedelbably fibrinogenalbuminratioasapredictormarkerofdiseaseactivityinankylosingspondylitis